Gel-Chewable Dosage Form Patent Application

USPTO published patent application US20260091023A1 (Application No. 19412073) for a gel-chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in lipid material, embedded in the gel matrix with at least a second active pharmaceutical ingredient. The formulation is designed for treating gastrointestinal tract diseases and disorders.

Pharmaceutical companies developing oral drug delivery systems should monitor this application for potential competitive implications. Patent applicants and competitors may want to conduct prior art searches around the disclosed lipid encapsulation and gel-chewable formulation techniques. No immediate compliance action or regulatory response is required for third parties.